arrow
I

Ines Zanna

Institute for Cancer Research
H指数:31
被引数:2,810

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transcriptomic deconvolution reveals prognostic immune signatures and immunotherapy-responsive subtypes in male breast cancer

转录组去卷积揭示了男性乳腺癌中的预后免疫特征和免疫治疗反应性亚型

2026-04-070
OAAI
The APC I1307K variant and male breast cancer risk: a multicenter case-control study in Italy

APC I1307K变异与男性乳腺癌风险:一项意大利多中心病例对照研究

2025-12-010
OAAI
Melanoma in Primary Care: A Narrative Review of Training Interventions and the Role of Telemedicine in Medical Education

全科医疗中的黑色素瘤:关于培训干预措施和远程医疗在医学教育中作用的叙事性综述

2025-09-290
OAAI
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study

男性乳腺癌风险与BRCA1/2以外基因的致病变异相关: 一项意大利病例对照研究

2023-07-017
OAAI
Common Susceptibility Loci for Male Breast Cancer
2020-08-1214
OAAI
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy

通过多基因面板测试了解男性乳腺癌的遗传易感性: 意大利多中心研究的结果

2019-01-2441
OAAI
Contribution of MUTYH Variants to Male Breast Cancer Risk: Results From a Multicenter Study in Italy

MUTYH变异对男性乳腺癌风险的贡献: 意大利多中心研究的结果

2018-12-0422
OAAI
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy

FANCM突变在男性乳腺癌易感性中的可能作用: 意大利多中心研究的结果

BREAST
IF7.9
2018-04-0117
PREAI
Whole-Exome Sequencing and Targeted Gene Sequencing Provide Insights Into the Role of PALB2 as a Male Breast Cancer Susceptibility Gene
CANCER
IF5.1
2016-09-2030
OAAI
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
2016-02-0987
OAAI